BONMAX PTH PEN DEVICE

Bonmax PTH Pen Device contains the active ingredient Teriparatide. Bonmax PTH Pen Device for is a synthetic form of PTH, a hormone that parathyroids (PTH) make by parathyroid glands, and is used to treat osteoporosis. Osteoporosis is a disease characterized by weak bones, increasing the chance of fractures. Osteoporosis-related fractures could seriously affect a person’s health, which can cause pain and hinder mobility. Bonmax PTH Pen Device functions by encouraging the growth of new bone tissue as well as increasing the density of bone. The medication has been proven to speed up bone healing for patients suffering from fractures. It helps to create a callus, the bridge of bone that is formed as healing proceeds, leading to quicker and more effective healing.
Patients who are suffering from an allergy or hypersensitivity to the Bonmax PTH Pen Device or one of its components should not take this drug. It is not recommended for those who have a history of skeletal malignancies such as osteosarcoma or those who have bone metastases. If a patient has had previous radiation therapy that involved the skeleton, then the usage of this drug is not recommended due to the possibility of developing osteosarcoma.